• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性有症状肺栓塞患者的收缩压与死亡率。

Systolic blood pressure and mortality in acute symptomatic pulmonary embolism.

机构信息

Respiratory Department, Hospital Ramón y Cajal and Universidad de Alcalá (IRYCIS), Madrid, Spain.

Respiratory Department, Hospital Ramón y Cajal and Universidad de Alcalá (IRYCIS), Madrid, Spain.

出版信息

Int J Cardiol. 2020 Mar 1;302:157-163. doi: 10.1016/j.ijcard.2019.11.102. Epub 2019 Nov 14.

DOI:10.1016/j.ijcard.2019.11.102
PMID:31761399
Abstract

BACKGROUND

The optimal cutoff for systolic blood pressure (SBP) level to define high-risk pulmonary embolism (PE) remains to be defined.

METHODS

To evaluate the relationship between SBP levels on admission and mortality in patients with acute symptomatic PE, the current study included 39,257 consecutive patients with acute symptomatic PE from the RIETE registry between 2001 and 2018. Primary outcomes included all-cause and PE-specific 30-day mortality. Secondary outcomes included major bleeding and recurrent venous thromboembolism (VTE).

RESULTS

There was a linear inverse relationship between admission SBP and 30-day all-cause and PE-related mortality that persisted after multivariable adjustment. Patients in the lower SBP strata had higher rates of all-cause death (reference: SBP 110-129 mmHg) (adjusted odds ratio [OR] 2.9; 95% confidence interval [CI], 2.0-4.2 for SBP <70 mmHg; and OR 1.7; 95% CI, 1.4-2.1 for SBP 70-89 mmHg). The findings for 30-day PE-related mortality were similar (adjusted OR 4.4; 95% CI, 2.7-7.2 for SBP <70 mmHg; and OR 2.6; 95% CI, 1.9-3.4 for SBP 70-89 mmHg). Patients in the higher strata of SBP had significantly lower rates of 30-day all-cause mortality compared with the same reference group (adjusted OR 0.7; 95% CI, 0.5-0.9 for SBP 170-190 mmHg; and OR 0.6; 95% CI, 0.4-0.9 for SBP >190 mmHg). Consistent findings were also observed for 30-day PE-related death.

CONCLUSIONS

In patients with acute symptomatic PE, a low SBP portends an increased risk of all-cause and PE-related mortality. The highest mortality was observed in patients with SBP <70 mmHg.

摘要

背景

收缩压(SBP)水平定义高危肺栓塞(PE)的最佳截断值仍有待确定。

方法

为评估急性有症状性 PE 患者入院时 SBP 水平与死亡率之间的关系,本研究纳入了 2001 年至 2018 年 RIETE 注册中心的 39257 例连续急性有症状性 PE 患者。主要结局包括全因和 PE 特异性 30 天死亡率。次要结局包括大出血和复发性静脉血栓栓塞(VTE)。

结果

入院时 SBP 与 30 天全因和 PE 相关死亡率呈线性反比关系,多变量调整后仍持续存在。SBP 较低分层的患者全因死亡率更高(参考:SBP 110-129mmHg)(校正比值比[OR] 2.9;95%置信区间[CI],SBP <70mmHg 为 2.0-4.2;SBP 70-89mmHg 为 1.7;95%CI,1.4-2.1)。30 天 PE 相关死亡率的结果相似(校正 OR 4.4;95%CI,SBP <70mmHg 为 2.7-7.2;SBP 70-89mmHg 为 2.6;95%CI,1.9-3.4)。与同一参考组相比,SBP 较高分层的患者 30 天全因死亡率显著降低(校正 OR 0.7;95%CI,SBP 170-190mmHg 为 0.5-0.9;SBP >190mmHg 为 0.6;95%CI,0.4-0.9)。PE 相关死亡也观察到了一致的结果。

结论

在急性有症状性 PE 患者中,低 SBP 预示全因和 PE 相关死亡率增加。SBP <70mmHg 的患者死亡率最高。

相似文献

1
Systolic blood pressure and mortality in acute symptomatic pulmonary embolism.急性有症状肺栓塞患者的收缩压与死亡率。
Int J Cardiol. 2020 Mar 1;302:157-163. doi: 10.1016/j.ijcard.2019.11.102. Epub 2019 Nov 14.
2
Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index?RIETE注册研究中血流动力学不稳定的肺栓塞:收缩压还是休克指数?
Eur Respir J. 2007 Dec;30(6):1111-6. doi: 10.1183/09031936.00071007. Epub 2007 Sep 5.
3
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism.心率与急性有症状肺栓塞患者的死亡率。
Chest. 2022 Feb;161(2):524-534. doi: 10.1016/j.chest.2021.08.059. Epub 2021 Aug 31.
4
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.在伴有收缩功能障碍和/或心力衰竭的急性心肌梗死患者中,整个随访期间的平均收缩压和舒张压与心血管事件之间的关系:来自高危心肌梗死数据库倡议的分析。
Eur J Heart Fail. 2018 Feb;20(2):323-331. doi: 10.1002/ejhf.1131. Epub 2018 Jan 4.
5
Interaction of systolic blood pressure and resting heart rate with clinical outcomes in takotsubo syndrome: insights from the International Takotsubo Registry.在 Takotsubo 综合征中收缩压和静息心率与临床结局的相互作用:来自国际 Takotsubo 注册研究的结果。
Eur J Heart Fail. 2018 Jun;20(6):1021-1030. doi: 10.1002/ejhf.1162. Epub 2018 Mar 8.
6
Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.射血分数保留的住院心力衰竭患者次日收缩压与出院后死亡率的关系。
Int Heart J. 2019 Jul 27;60(4):876-885. doi: 10.1536/ihj.18-699. Epub 2019 Jun 28.
7
Combining heart rate and systolic blood pressure to improve risk stratification in older patients with heart failure: Findings from the RICA Registry.结合心率和收缩压以改善老年心力衰竭患者的风险分层:RICA注册研究结果
Int J Cardiol. 2017 Mar 1;230:625-629. doi: 10.1016/j.ijcard.2016.12.041. Epub 2016 Dec 27.
8
Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.简化肺栓塞严重指数评分对低危肺栓塞合并活动性癌症患者的识别作用:来自 COMMAND VTE 注册研究。
Chest. 2020 Mar;157(3):636-644. doi: 10.1016/j.chest.2019.08.2206. Epub 2019 Oct 9.
9
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.静脉血栓栓塞和癌症患者的三个月死亡率和临床预测因素。RIETE 登记处的结果。
Thromb Res. 2013 Jan;131(1):24-30. doi: 10.1016/j.thromres.2012.10.007. Epub 2012 Nov 8.
10
Association of age and baseline systolic blood pressure with outcomes in patients hospitalized for acute heart failure syndromes.急性心力衰竭综合征住院患者的年龄及基线收缩压与预后的关系
Int J Cardiol. 2015 Jul 15;191:100-6. doi: 10.1016/j.ijcard.2015.04.258. Epub 2015 May 1.

引用本文的文献

1
Association between genetic risk and adherence to the Dietary Approaches to Stop Hypertension diet for developing venous thromboembolism.遗传风险与坚持终止高血压膳食方法饮食预防静脉血栓栓塞之间的关联。
Res Pract Thromb Haemost. 2025 Mar 12;9(2):102731. doi: 10.1016/j.rpth.2025.102731. eCollection 2025 Feb.
2
Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality.影像学和生物标志物:肺栓塞风险和早期死亡率评估。
Medicina (Kaunas). 2024 Sep 12;60(9):1489. doi: 10.3390/medicina60091489.
3
Association Between Systolic Blood Pressure and in-Hospital Mortality Among Congestive Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: A Retrospective Cohort Study.
在重症监护病房中,患有慢性阻塞性肺疾病的充血性心力衰竭患者的收缩压与住院死亡率之间的关系:一项回顾性队列研究。
Int J Chron Obstruct Pulmon Dis. 2024 Sep 13;19:2023-2034. doi: 10.2147/COPD.S448332. eCollection 2024.
4
[Pulmonary Embolism].[肺栓塞]
Open Respir Arch. 2024 Jun 4;6(4):100342. doi: 10.1016/j.opresp.2024.100342. eCollection 2024 Oct-Dec.
5
Association between severity of pulmonary embolism and health-related quality of life.肺栓塞严重程度与健康相关生活质量的关系。
J Thromb Haemost. 2024 Feb;22(2):516-525. doi: 10.1016/j.jtha.2023.10.016. Epub 2023 Oct 30.
6
Risk of early clinical deterioration and 30-day mortality in pulmonary embolism intermediate-high-risk patients with patent foramen ovale.卵圆孔未闭的中高危肺栓塞患者早期临床恶化和 30 天死亡率的风险。
Intern Emerg Med. 2024 Sep;19(6):1637-1644. doi: 10.1007/s11739-024-03657-w. Epub 2024 May 31.
7
Mechanical Support in High-Risk Pulmonary Embolism: Review Article.高危肺栓塞的机械支持:综述文章
J Clin Med. 2024 Apr 24;13(9):2468. doi: 10.3390/jcm13092468.
8
Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol.比较两种复方口服避孕药(炔诺酮/炔雌醇和屈螺酮/炔雌醇)的深静脉血栓形成风险。
Heliyon. 2024 Feb 18;10(5):e26462. doi: 10.1016/j.heliyon.2024.e26462. eCollection 2024 Mar 15.
9
Prognosis of Postoperative Pulmonary Embolism in High Altitude.高海拔地区术后肺栓塞的预后
Cureus. 2023 Oct 2;15(10):e46358. doi: 10.7759/cureus.46358. eCollection 2023 Oct.
10
Developing a nomogram-based scoring model to estimate the risk of pulmonary embolism in respiratory department patients suspected of pulmonary embolisms.开发一种基于列线图的评分模型,以评估呼吸科疑似肺栓塞患者发生肺栓塞的风险。
Front Med (Lausanne). 2023 May 17;10:1164911. doi: 10.3389/fmed.2023.1164911. eCollection 2023.